Clinical Trials Browser

Advanced Gastric Cancer × durvalumab × Clear all

NCT03579784 2024-04-19

Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Advanced Gastric Cancer